Consistent with the results in vitro, OMT inhibited Arg-induced AP and intestinal injury in vivo along with the inhibition of Arg-induced inflammation (TNF-α, IL-6, IL-1β, NF-κB) and p38/ERK-MAPK signalling. The gene discussed is IL1B; the disease is alkaline phosphatase measurement.